NDC 0169-2100

NOVOLOG

Insulin Aspart

NOVOLOG is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Insulin Aspart.

Product ID0169-2100_701d5c2d-21d9-414a-a946-236bcb198a37
NDC0169-2100
Product TypeHuman Prescription Drug
Proprietary NameNOVOLOG
Generic NameInsulin Aspart
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2001-08-27
Marketing CategoryBLA /
Application NumberBLA020986
Labeler NameNovo Nordisk
Substance NameINSULIN ASPART
Active Ingredient Strength100 [iU]/mL
Pharm ClassesInsulin [CS],Insulin Analog [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0169-2100-11

1 VIAL, GLASS in 1 CARTON (0169-2100-11) > 10 mL in 1 VIAL, GLASS
Marketing Start Date2021-05-25
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "NOVOLOG" or generic name "Insulin Aspart"

NDCBrand NameGeneric Name
0169-2100NOVOLOGinsulin aspart
0169-2101NOVOLOGinsulin aspart
0169-3303NOVOLOGinsulin aspart
0169-6338NOVOLOGinsulin aspart
0169-6339NOVOLOGinsulin aspart
0169-7501NOVOLOGinsulin aspart
50090-1664NOVOLOGinsulin aspart
50090-1665NovoLoginsulin aspart
50090-1678NOVOLOGinsulin aspart
68258-8899NovoLogNovoLog
64725-0750NovoLogNovoLog
70518-2252NOVOLOGNOVOLOG
0169-2200NovoLog Mix 70/30insulin aspart
0169-2201NovoLog Mix 70/30insulin aspart
0169-3685NovoLog Mix 70/30insulin aspart
0169-3696NovoLog Mix 70/30insulin aspart

Trademark Results [NOVOLOG]

Mark Image

Registration | Serial
Company
Trademark
Application Date
NOVOLOG
NOVOLOG
75812138 2413874 Live/Registered
Novo Nordisk A/S
1999-10-01
NOVOLOG
NOVOLOG
75421022 2295132 Dead/Cancelled
Novo Nordisk A/S
1998-01-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.